Cargando…

Gut Microbiome and Intestinal Permeability Are Promising Targets for Treating Nonalcoholic Fatty Liver Disease

Background: Nonalcoholic fatty liver disease (NAFLD) is a leading liver disease worldwide with a prevalence of approximately 24% among adult population. It is a spectrum of liver disorders ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). Obesity, insulin resistance, inflammation...

Descripción completa

Detalles Bibliográficos
Autor principal:	Heshmati, Hassan Massoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265987/ http://dx.doi.org/10.1210/jendso/bvab048.024

Ejemplares similares

FRI037 Time-restricted Feeding Prevents Progression Of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Through IPMK
por: Jung, Ik-Rak, et al.
Publicado: (2023)

ODP008 Nonalcoholic Fatty Liver Disease (NAFLD) Impacts Weight Loss after Bariatric Surgery
por: Abu-Rumaileh, Mohammed, et al.
Publicado: (2022)

SAT-109 tiRNA-5 Reflects the Severity of Mitochondrial Oxidative Stress in Nonalcoholic Fatty Liver Disease
por: Yang, Yashuang, et al.
Publicado: (2019)

SAT-111 Reversal of Nonalcoholic Fatty Liver Disease with Bariatric Surgery in South Asians: Does the Type of Surgery Matter?
por: Wijetunga, Udai, et al.
Publicado: (2019)

SUN-095 Attenuation of Inflammation by a Novel Small Molecule Prevents High Fat Diet-Induced Nonalcoholic Fatty Liver Disease
por: Patton, Ashley, et al.
Publicado: (2019)

MON-LB104 Update on Anti-Obesity Medical Devices
por: Heshmati, Hassan M
Publicado: (2020)

SAT-110 Long-Term Impact of Gastric Bypass versus Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease: Retrospective Observations from Michigan Bariatric Surgery Cohort
por: Haddad, Raad, et al.
Publicado: (2019)

SUN-LB020 The Role of Estradiol and Diet on the Gut Microbiome
por: Thumuluri, Deepthi, et al.
Publicado: (2019)

ODP003 Different Phenotypes of Obesity: Focus on The Intestinal Microbiom and The Adipomyokin Profile
por: Volkova, Natalya, et al.
Publicado: (2022)

SAT-104 Reversal of Nonalcoholic Fatty Liver Disease with Bariatric Surgery in South Asians: Has the Cure Been Finally Found? Real World Data From a Sri Lankan Tertiary Care Setting
por: Wijetunga, Udai, et al.
Publicado: (2019)

PSUN82 The Gut Microbiome Regulates Healthy Adipose Tissue Expansion via the Action of FFA2
por: Nnyamah, Christine, et al.
Publicado: (2022)

Are Obese Patients Evaluated for Non-Alcoholic Fatty Liver Disease in an Endocrinology Outpatient Clinic?
por: Irazusta, Florencia, et al.
Publicado: (2021)

SAT-118 Gastric Sleeve for Adjunctive Management of Nonalcoholic Steatohepatitis: A Case Report
por: Horowitz, Alex, et al.
Publicado: (2019)

SAT-LB016 Diabetes and Non-Alcoholic Fatty Liver Disease in Two Patients with ROHHAD Syndrome
por: Sprague, Jennifer, et al.
Publicado: (2019)

MON-592 The Impact of Bariatric Surgery on the Risk of Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Obese Type Two Diabetes Patients in an Endocrine Clinic
por: Shaghouli, Amna Ali, et al.
Publicado: (2021)

PSUN121 Nonalcoholic Steatohepatitis (NASH), Race/Ethnicity, and Gender in Adult US Population of NHANES 17-18
por: Friedman, Theodore, et al.
Publicado: (2022)

MON-597 Non-Alcoholic Fatty Liver Disease Determined by MRI and Its Association with Metabolic Variables in Non-Diabetic Subjects
por: Da Silva, Debora Gonçalves, et al.
Publicado: (2020)

FRI036 Trends In The Racial And Ethnic Disparity Of Metabolic Associated Fatty Liver Disease (MAFLD): Data From NHANES 1988 To 2018
por: Shaheen, Magda, et al.
Publicado: (2023)

FRI076 Colchicine Treatment Effects On The Gut Microbiome In Adults With Metabolic Syndrome, Insulin Resistance, And High C-reactive Protein (CRP): A Secondary Analysis Of A Randomized, Placebo-controlled Clinical Trial
por: Kisimba, Celine M, et al.
Publicado: (2023)

FRI001 Tanycytic Thyroid-stimulating Hormone Receptor Activation Increases Blood-Hypothalamus Barrier Permeability And Induces Appetite In Female Mice
por: Kannangara, Hasni Suhasha, et al.
Publicado: (2023)

Profile of Intestinal Microbiota and Anxiety Level in Overweight Children and Adolescents
por: Bandeira Farias, Maria Paula Costa, et al.
Publicado: (2021)

FRI009 Microbiome Affects Host Metabolic Homeostasis Via Differential Regulation Of Gene Expression In The Endocrine System
por: Milhouse, Wynne, et al.
Publicado: (2023)

MON-112 Gelesis100 Reduces Insulin Resistance in Patients Who Are Overweight or Have Obesity with High Insulin Resistance: Results of the GLOW Study
por: Greenway, Frank, et al.
Publicado: (2019)

SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study
por: Greenway, Frank, et al.
Publicado: (2019)

MON-594 The Peculiarity of the Gut Microbiota in Patients with Different Phenotypes of Obesity (Pilot Study)
por: Volkova, Natalia, et al.
Publicado: (2020)

FRI013 Free Fatty Acid Receptors 2 And 3 Mediate The Beneficial Effects Of Fiber
por: Pandya, Nupur S, et al.
Publicado: (2023)

Abnormal Non Esterified Fatty Acid Suppression After a Mixed Meal Test in Patients With Partial Lipodystrophy
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

Fatty Acids Modify the MicroRNA Content of Exosomes Released by Hypothalamic Astrocytes and the Response of POMC Neurons to These Exosomes
por: Collado-Pérez, Roberto, et al.
Publicado: (2021)

FRI010 Human Gut Microbiota And Metabolic Profiles Are Associated With Obesity In Five African-Origin Populations
por: Jorgensen, Julianne, et al.
Publicado: (2023)

Mice Deficient for an Intestinal G Protein-Coupled Receptor Expression Have Increased Satiety During Rebound Hyperphagia
por: Yan, Shijun, et al.
Publicado: (2021)

OR23-4 Intestinal FFA2 and FFA3 Mediate Obesogenic Effects in Mice on a Western Diet
por: Gough, Sophie, et al.
Publicado: (2022)

FRI029 Chronic Free Fatty Acid Elevation Is Associated With An Overcompensatory Increase In Hepatic Mitochondrial Function In Patients With Overweight Or Obesity
por: Bril, Fernando, et al.
Publicado: (2023)

LBODP109 Astrocytes Affect The Metabolism Of Proopiomelanocortin (pomc) Neurons Through The Release Of Exosomes That Are Modified In A Fatty Acid Specific Manner
por: Collado-Pérez, Roberto, et al.
Publicado: (2022)

SUN-092 Distinct Changes in Gut Microbiota Are Associated with Estradiol-Mediated Protection from Diet-Induced Obesity in Female Mice
por: Acharya, Kalpana, et al.
Publicado: (2019)

Adiposity Profiles and Insulin Resistance in Urban and Rural Indonesian Young Adults and Its Association With Gut Inflammation Marker Lipocalin-2
por: Kurniawan, Farid, et al.
Publicado: (2021)

FRI063 Effectiveness Of Liraglutide In Treating Obesity And Improving Hepatic Steatosis
por: Alfadda, Assim Abdulaziz, et al.
Publicado: (2023)

MON-LB022 Gelesis Novel, Non-Systemic, Superabsorbent Hydrogel Improves Intestinal Barrier Function in Mice with DSS Induced Colitis
por: Silvestri, Alessandra, et al.
Publicado: (2019)

OR01-1 Leveraging Immunometabolic Control to Prevent and Treat Obesity Related Asthma
por: Burak, M. Furkan, et al.
Publicado: (2019)

MON-586 Gut Hormones Response to 24-H High Carbohydrate Overfeeding Is a Determinant of Metabolic Adaptation to Carbohydrate Intake in Healthy Individuals
por: Vinales, Karyne Lima, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ddvhff0jl2skncdvabm06c6o9j